Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02953860
Title Fulvestrant Plus Enzalutamide in ER+/Her2- Advanced Breast Cancer
Recruitment Completed
Gender female
Phase Phase II
Variant Requirements No
Sponsors Anthony Elias
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
University of Colorado Aurora Colorado 80045 United States Details
Lone Tree Medical Center Lone Tree Colorado 80124 United States Details
West Cancer Center Germantown Tennessee 38138 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field